R99-214 AUTHORIZING THE FILING AND EXECUTION OF AMENDMENT NO. 1

Home Browse Search

" - � r . � f. CERTIFICATIONS AND ASSURANCES REQUIRED OF EACH GRANTEE ' � A. Authority of Grantee and Its Representative The authorized representative of the Grantee and legal counsel who sign these certifications, assurances, and agreements attest that both the Grantee and its authorized representative have adequate authority under state and local law and the by-laws or internal rules of the Grantee organization to: (1) Execute and file the applications for federal assistance on behalf of the Grantee, (2) Execute and file the required certiflcations, assurances, and agreements on behalf of the Grantee binding the Grantee, and (3) Execute grant and cooperative agreements with FTA or IDOT on behalf of the Grantee. B. Standard Assurances The Grantee assures that it will comply with all applicable state 8 federal statutes, regulations, executive _ orders, FTA circulars, and other federal administrative requirements in carrying out any grant or cooperative • agreement awarded by FTA. The Grantee acknowledges that it is under a continuing obligation to comply with the terms and conditions of the grant or cooperative agreement issued for its approved Project with IDOT or FTA. The Grantee understands that federal laws, regulations, policies, and administrative practices might be modified from time to time and affect the implementation of the Project. The Grantee agrees that the most recent state & federal requirements will apply to the Project, unless IDOT or FTA issues a written determination otherwise. C. Debarment Suspension and Other Responsibility Matters Primary Covered Transactions In accordance with U.S. Department of Transportation (U.S. DOT) regulations on Govemment wide Debarment and Suspension (Nonprocurement) at 49 CFR 29.510, the Grantee certifies to the best of its knowledge and belief, that it and its principals: (1) Are not presently debarred, suspended, proposed for Debarment, declared ineligible, or voluntarily excluded from covered transactions by any federal department or agency; (2) Have not within a three-year period preceding this Agreement been convicted of or had a civil judgment rendered against them for commission of fraud or a criminal offense in connection with obtaining, attempting to obtain, or performing a public (federal, state, or locat) transaction or contract under a public transaction; violation of federal or state antitrust statutes; or commission of embeulement, theft, forgery, bribery, falsification or destruction of records, making false statements, or receiving stolen property; (3j Are not presently indicted for or otherwise criminally charged or by civil action by a govemmental entiry (federal, state or local) with commission of any of the offenses listed in paragraph (2) of this certification; and, (4) Have not within a three year period preceding this Agreement had one or more public transactions (federal, state, or local)terminated for cause or default. . The Grantee certifies that if it becomes aware of any later information that contradicts the statements in paragraphs (1) through (4) above, it will promptly inform IDOT. Should the Grantee be unable to certify to statements set forth in paragraphs (1)through (4)above, it shall so acknowledge with its signature and provide a written exptanation to IDOT. D. Drug-Fr+ee Workplace Ce�cafion tn accordance with Illinois and U.S. DOT regulations on Drug-Free Wo�icplace Requirements (Grants) at 30 ILCS 580/1 et seq. and 49 CFR 29.630, the Grantee certifies that it will provide a drug-free workplace by: (1) Publishing a statement notifying employees that the unlawful manufacture, distribution, dispensing, possession, or use of a controlled substance is prohibited in the Grantee's workplace and specifying the - � actions that will be taken against employees for violation of such prohibition; {2): Establistiing an orrgoing drug-free awareness program to inform employees about: . � (a) the dangers of drug abuse in the workplace; � • (b) the Grantee's policy of maintaining a drug-free workplace; REV:1/8/99 2